Pickens, P.T. , Bumpus, F.M., Lloyd , A.M., et al.: Measurement of renin activity in human plasma. Circ. Res., 17: 438, 1965.
2.
Brown, J.J., Davies, D.L., Lever, A.F., et al.: The estimation of renin in human plasma. Biochem. J., 93: 594, 1964.
3.
Skinner, S.L. : Improved assay methods for renin concentration and activity in human plasma. Circ. Res., 20: 391, 1967.
4.
Skinner, S.L. , Cran, E.J., Gibson , R., et al.: Angiotensin I and II, active and inactive renin, renin substrate, renin activity and angiotensinase in human liquor amnii and plasma. Am. J. Obstet. Gynecol. , 121: 626, 1975.
5.
Derckx, F.H.M. , Wenting, G.J., Man in 't Veld , A.J., et al.: Inactive renin in human plasma. Lancet, 2: 496, 1976.
6.
Boyd, G.W.: An inactive higher-molecular-weight renin in normal subjects and hypertensive patients. Lancet, 1: 215, 1977.
7.
Catt, K.J., Cain, M.C., Coghlan, J.P.: Measurement of angiotensin II in blood. Lancet, 2: 1005, 1967.
8.
Boyd, G.W., Landon, J., Peart, W.S.: Radioimmunoassay for determining plasma levels of angiotensin II in man. Lancet, 2: 1002, 1967.
9.
Amery, A., Lijnen, P., Fagard, R., et al.: Plasma renin activity vs concentration. N. Engl. J. Med., 295: 1199, 1976.
10.
Reybrouck, T., Amery, A., Billiet , L.: Hemodynamic response to exercise after chronic beta adrenergic blockade. J. Appl. Physiol., 42: 133, 1977.
11.
Vallotton, M.B. : In Immunological Methods in Endocrinology . Edited by R. Levine, E. F. Pfeifer.New York, Academic Press, 1971, p. 94.
12.
Lijnen, P., Amery, A., Fagard, R.: Comparison between a biological and a radio-immunological assay of plasma renin concentration. FEBS Lett., 61: 32, 1976.
13.
Lijnen, P., McCaa, R., Amery, A., et al.: Modified radioimmunoassay for peripheral plasma aldosterone . FEBS Lett., 54: 84, 1975.
14.
Lijnen, P., Amery, A., Fagard, R.: Radioimmunoassay of plasma angiotensin II. (Submitted for publication.)
15.
Weidmann, P. , De Myttenaere-Bursztein , S., Maxwell, M., et al.: Effect of aging on plasma renin and aldosterone in normal man. Kidney Int., 8: 325, 1975.
16.
Lucas, C.P. , Holzwarth, G., Ocobock , R., et al.: Renin: Activity, reactivity and concentration in a population survey. Relationship to blood pressure. Angiology , 26: 31, 1975.
17.
Brunner, H.R. , Laragh, J.H., Baer , L.: Essential hypertension: Renin and aldosterone, heart attack and stroke. N. Engl. J. Med., 286: 441, 1972.
18.
Woods, J.W. , Pittman, A.W., Pulliam , C.C., et al.: Renin profiling in hypertension and its use in treatment with propranolol and chlorthalidone . N. Engl. J. Med., 294: 1137, 1976.
19.
Bühler, F.R. : Essentielle Hypertonie: Renin und Aldosterone, Schlüssel zu Pathogenese und Therapie?Schweiz. Med. Wochenschr. , 104: 1014, 1974 .
20.
Hayduck, K., Krause, D.K., Kaufman, W., et al.: Age-dependent changes of plasma renin concentration in humans . Clin. Sci. Mol. Med., 45: 273s, 1973.
21.
Flood, C., Gherondacke, C., Pincus, G., et al.: The metabolism and secretion of aldosterone in elderly subjects . J. Clin. Invest., 46: 960, 1967.
22.
Schalekamp, M.A.D.H., Krauss, X.H., Schalekamp-Kuyken , M.P.A., et al.: Studies on the mechanism of hypernatriuresis in essential hypertension in relationship to measurements of plasma renin concentration, body fluid components and renal function. Clin. Sci., 41: 219, 1971.
23.
Tuck, M.L., Williams, G.H., Cain, J.P., et ai.: Relation of age, diastolic blood pressure and known duration of hypertension to presence of low renin essential hypertension. Am. J. Cardiol., 32: 637, 1973.
24.
W mer, N., Chokshi, D.S., Yoon, M.S.: Adrenergic receptor mediation of renin secretion. J. Clin. Endocrinol., 29: 1168, 1969.
25.
Michelakis, A.M., McAllister, R.G.: The effect of chronic adrenergic receptor blockade on plasma renin activity. J. Clin. Endocrinol. , 34: 386, 1972.
26.
Bühler, F.R. , Laragh, J.H., Bear , L.: Propranolol inhibition of renin secretion: A specific approach to diagnosis and treatment of renin-dependent hypertensive disease. N. Engl. J. Med., 287: 1209, 1972 .
27.
Åberg, H.: Plasma renin activity after the use of a new beta-adrenergic blocking agent . Int. J. Clin. Pharmacol. Ther. Toxicol., 9: 98, 1974.
28.
Sassard, J. , Pozet, N., Vincent , M.: Atenolol and renin secretion. N. Engl. J. Med., 294: 787, 1976 .
29.
Attman, P.O. , Aurell, M., Johnson , G.: Effect of metoprolol and propranolol on furosemide-stimulated renin release in healthy subjects . Eur. J. Clin. Pharmacol. , 8: 201, 1975.
30.
Amery, A., Billiet, L., Fagard, R.: Beta receptors and renin release. N. Engl. J. Med. , 290: 284, 1974.
31.
Birkenhäger, W.H., Krauss, X.H., Schalekamp , M.A.D.H., et al.: Antihypertensive effect of propranolol: Observations on predictability. Folia Med. Neerl. , 14: 67, 1971.
32.
Lijnen, P., Amery, A., De Plaen, J.F., et al.: In Beta-Adrenoceptor Blocking Agents. Edited by P. R. Saxena, R. P.Forsyth. Amsterdam, North Holland Publishing, 1976, p. 334.
33.
Verniory, A. , Staroukine, M., Delniche , F., et al.: Effect of sotalol on hemodynamics and renin-angiotensin-aldosterone system in hypertensive patients. Clin. Sci. Mol. Med., 51: 9, 1976.
34.
Oparil, S., Vassaux, C., Sanders, C.A.: Role of renin in acute postural homeostasis. Circulation , 41: 89, 1970.
35.
Sealey, J.F. , Bühler, F.R., Laragh, J.H., et al.: In Hypertension Manual. Edited by J. H. Laragh.New York, Yorke Medical Books, 1973, p. 537.
36.
Pettinger, W.A., Mitchell, H.C.: Renin release, saralasin and the vasodilator-beta blocker drug interaction in man. N. Engl. J. Med., 292: 1214, 1975.
37.
Case, D.B., Wallace, J.M., Keim, H.J., et al.: Usefulness and limitations of saralasin, a partial competitive agonist of angiotensin II, for evaluating the renin and sodium factors in hypertensive patients. Am. J. Med., 60: 825, 1976.
38.
Robertson, J.I.S.: The effects of the angiotensin II antagonist saralasin on blood pressure and plasma aldosterone in man in relation to pre-infusion plasma angiotensin II concentration. Prog. Biochem. Pharmacol. , (In press).
39.
Leckie, B., Brown, J.J., Lever, A.F., et al.: Inactive renin in human plasma. Lancet, 2: 1412, 1976.
40.
Crane, M.G. , Heitsch, J., Harris , J.J., et al.: Effect of ethinyl estradiol (Estinyl) on plasma renin activity. J. Clin. Endocrinol., 26: 1403, 1966.
41.
Helmer, O.M. , Judson, W.E.: Influence of high renin substrate on renin-angiotensin system in pregnancy. Am. J. Obstet. Gynecol. , 99: 9, 1967.
42.
Skinner, S.L. , Lumbers, E.R., Symonds , E.M.: Alteration by oral contraceptives of normal menstrual changes in plasma renin activity, concentration and substrate. Clin. Sci., 36: 67, 1969.